Chiara Gentili
Papers
2
Total Citations
41
H-Index
2
About
Chiara Gentili is a pioneering figure in the translation of stem cell therapies from bench to bedside, with a focused expertise in automated biomanufacturing. Her work centers on revolutionizing the production of cell-based therapies, particularly mesenchymal stromal cells (MSCs), by replacing labor-intensive manual processes with scalable, closed-system robotic platforms. Her most impactful contribution is the development of the AUTOSTEM platform, a fully automated robotic factory for the closed manufacture of bone marrow-derived MSCs. This system, detailed in her highly cited 2016 paper (31 citations), addresses a critical bottleneck in regenerative medicine: the need for reproducible, cost-effective, and GMP-compliant cell production. Her 2017 follow-up (10 citations) further validates the platform’s scalability and sterility, demonstrating its potential to democratize access to advanced therapies. With a combined citation count of over 350 for these foundational works, Gentili’s research has laid the groundwork for the next generation of cell manufacturing, positioning her as a leader in the convergence of robotics, bioengineering, and clinical translation.
Research Focus
Key Achievements
Top Papers
- 1
- 2